* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
IJGC Podcast
The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer. Join Editor-in-Chief Dr. Pedro Ramirez and his guests for an interactive and educational experience. Subscribe now or listen on your favourite podcast platform. IJGC - ijgc.bmj.com - is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
Listen on:
Episodes
Tuesday Jan 22, 2019
Tuesday Jan 22, 2019
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Soslow from Memorial Sloan Kettering Cancer Center to talk about the importance and clinical relevance of a classification in patients with cervical cancer, particularly cervical adenocarcinoma. They discuss the way that cervical adenocarcinoma has been classified historically, the potential impact of a new classification scheme on clinical outcomes, and integrating testing in low resource areas. Look out for IJGC's upcoming podcast with Dr. Soslow on invasion pattern-based classification of HPV-associated endometrial carcinomas.
Tuesday Jan 15, 2019
Tuesday Jan 15, 2019
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas to talk about the management of rare ovarian tumors in ovarian cancers, including mucinous, clear cell, and small cell. They discuss metastatic vs. primary mucinous tumors, the role of HIPEC in the treatment of advanced disease, as well as genomic profiling. Look out for IJGC's upcoming pdocast with Dr. Gershenson on updates on management of low-grade ovarian tumors.
Tuesday Jan 08, 2019
Tuesday Jan 08, 2019
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.
Thursday Dec 20, 2018
Thursday Dec 20, 2018
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti (Twitter: @annafagottimd) from Policlinico Universitario Agostino Gemelli in Rome. Dr. Fagotti is the lead author of the Lead Article for the February 2018 issue, "The INTERNATIONAL MISSION study: Minimally Invasive Surgery In Ovarian Neoplasms after NACT." They discuss the origins and results of the study, what makes a patient an ideal candidate for minimally invasive surgery, and the next steps for evaluating oncologic outcomes.